Envista (NVST) Competitors

$23.94 -0.35 (-1.42%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$23.98 +0.04 (+0.17%)

As of 05/13/2026 07:02 PM Eastern

NVST vs. XRAY, BRBR, ZBH, SNN, and PEN

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), and Penumbra (PEN).

How does Envista compare to DENTSPLY SIRONA?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

In the previous week, Envista had 8 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 17 mentions for Envista and 9 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 0.62 beat DENTSPLY SIRONA's score of 0.29 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	4 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Envista presently has a consensus price target of $28.83, indicating a potential upside of 20.47%. DENTSPLY SIRONA has a consensus price target of $13.82, indicating a potential upside of 32.36%. Given DENTSPLY SIRONA's higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.43	$47M	$0.41	58.38
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$3.15	N/A

Summary

Envista beats DENTSPLY SIRONA on 10 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

Envista (NYSE:NVST) and BellRing Brands (NYSE:BRBR) are related companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
BellRing Brands	6.78%	-44.06%	19.42%

In the previous week, Envista had 5 more articles in the media than BellRing Brands. MarketBeat recorded 17 mentions for Envista and 12 mentions for BellRing Brands. Envista's average media sentiment score of 0.62 beat BellRing Brands' score of 0.09 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	4 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BellRing Brands	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

BellRing Brands has lower revenue, but higher earnings than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.43	$47M	$0.41	58.38
BellRing Brands	$2.32B	0.47	$216.20M	$1.29	7.17

Envista presently has a consensus price target of $28.83, indicating a potential upside of 20.47%. BellRing Brands has a consensus price target of $23.73, indicating a potential upside of 156.47%. Given BellRing Brands' higher probable upside, analysts clearly believe BellRing Brands is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
BellRing Brands	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37

Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, BellRing Brands has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

95.0% of BellRing Brands shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 1.5% of BellRing Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Envista and BellRing Brands tied by winning 8 of the 16 factors compared between the two stocks.

How does Envista compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

88.9% of Zimmer Biomet shares are owned by institutional investors. 1.3% of Zimmer Biomet shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Zimmer Biomet has a net margin of 9.05% compared to Envista's net margin of 2.41%. Zimmer Biomet's return on equity of 13.24% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Envista	2.41%	7.11%	3.91%

In the previous week, Envista had 7 more articles in the media than Zimmer Biomet. MarketBeat recorded 17 mentions for Envista and 10 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 0.85 beat Envista's score of 0.62 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	4 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zimmer Biomet has higher revenue and earnings than Envista. Zimmer Biomet is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	1.94	$705.20M	$3.85	21.47
Envista	$2.72B	1.43	$47M	$0.41	58.38

Zimmer Biomet has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market. Comparatively, Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market.

Zimmer Biomet currently has a consensus price target of $102.80, suggesting a potential upside of 24.35%. Envista has a consensus price target of $28.83, suggesting a potential upside of 20.47%. Given Zimmer Biomet's higher possible upside, analysts clearly believe Zimmer Biomet is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.26
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Zimmer Biomet beats Envista on 13 of the 17 factors compared between the two stocks.

How does Envista compare to Smith & Nephew SNATS?

Envista (NYSE:NVST) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Envista currently has a consensus target price of $28.83, suggesting a potential upside of 20.47%. Smith & Nephew SNATS has a consensus target price of $30.93, suggesting a potential upside of 3.65%. Given Envista's higher probable upside, research analysts plainly believe Envista is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Smith & Nephew SNATS	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.40

Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Envista has a net margin of 2.41% compared to Smith & Nephew SNATS's net margin of 0.00%. Envista's return on equity of 7.11% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Smith & Nephew SNATS	N/A	N/A	N/A

In the previous week, Envista had 15 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 17 mentions for Envista and 2 mentions for Smith & Nephew SNATS. Envista's average media sentiment score of 0.62 beat Smith & Nephew SNATS's score of 0.23 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	4 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Smith & Nephew SNATS has higher revenue and earnings than Envista.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.43	$47M	$0.41	58.38
Smith & Nephew SNATS	$6.16B	2.07	$625M	N/A	N/A

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Envista beats Smith & Nephew SNATS on 8 of the 14 factors compared between the two stocks.

How does Envista compare to Penumbra?

Envista (NYSE:NVST) and Penumbra (NYSE:PEN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Envista currently has a consensus target price of $28.83, suggesting a potential upside of 20.47%. Penumbra has a consensus target price of $361.33, suggesting a potential upside of 12.05%. Given Envista's stronger consensus rating and higher probable upside, research analysts plainly believe Envista is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Penumbra has a net margin of 11.76% compared to Envista's net margin of 2.41%. Penumbra's return on equity of 10.87% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Penumbra	11.76%	10.87%	8.45%

In the previous week, Envista had 9 more articles in the media than Penumbra. MarketBeat recorded 17 mentions for Envista and 8 mentions for Penumbra. Envista's average media sentiment score of 0.62 beat Penumbra's score of 0.03 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	4 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra has lower revenue, but higher earnings than Envista. Envista is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.43	$47M	$0.41	58.38
Penumbra	$1.40B	9.04	$177.69M	$4.34	74.30

88.9% of Penumbra shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 2.9% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Penumbra beats Envista on 9 of the 16 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVST vs. The Competition

Export

Metric	Envista	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$3.95B	$8.12B	$6.30B	$22.96B
Dividend Yield	N/A	2.50%	2.79%	4.07%
P/E Ratio	58.38	18.19	20.99	28.29
Price / Sales	1.43	8.35	555.98	24.55
Price / Cash	11.18	16.76	42.94	25.11
Price / Book	1.27	3.75	9.70	4.73
Net Income	$47M	$223.05M	$3.55B	$1.07B
7 Day Performance	-1.95%	-2.05%	-0.56%	-1.11%
1 Month Performance	-12.55%	3.40%	1.17%	1.36%
1 Year Performance	33.72%	1.89%	41.20%	24.41%

Envista Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVST Envista	3.4368 of 5 stars	$23.94 -1.4%	$28.83 +20.5%	+28.0%	$3.95B	$2.72B	58.38	12,000	Analyst Downgrade
XRAY DENTSPLY SIRONA	4.6347 of 5 stars	$11.20 -5.2%	$13.91 +24.2%	-37.1%	$2.37B	$3.68B	N/A	14,000
BRBR BellRing Brands	3.7629 of 5 stars	$17.32 +0.7%	$33.88 +95.6%	-85.5%	$2.02B	$2.32B	11.94	380	High Trading Volume
ZBH Zimmer Biomet	4.5394 of 5 stars	$82.73 -0.2%	$102.43 +23.8%	-15.1%	$16.05B	$8.23B	21.49	17,000
SNN Smith & Nephew SNATS	2.5601 of 5 stars	$30.92 -0.8%	$34.75 +12.4%	+5.6%	$13.30B	$6.16B	N/A	16,988	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NVST) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envista (NVST) Competitors

NVST vs. XRAY, BRBR, ZBH, SNN, and PEN

How does Envista compare to DENTSPLY SIRONA?

Summary

How does Envista compare to BellRing Brands?

Summary

How does Envista compare to Zimmer Biomet?

Summary

How does Envista compare to Smith & Nephew SNATS?

Summary

How does Envista compare to Penumbra?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envista (NVST) Competitors

NVST vs. XRAY, BRBR, ZBH, SNN, and PEN

How does Envista compare to DENTSPLY SIRONA?

Is NVST or XRAY more profitable?

Which has more volatility & risk, NVST or XRAY?

Does the media refer more to NVST or XRAY?

Do insiders and institutionals believe in NVST or XRAY?

Do analysts recommend NVST or XRAY?

Which has better valuation & earnings, NVST or XRAY?

Summary

How does Envista compare to BellRing Brands?

Is NVST or BRBR more profitable?

Does the media refer more to NVST or BRBR?

Which has better valuation & earnings, NVST or BRBR?

Do analysts recommend NVST or BRBR?

Which has more volatility & risk, NVST or BRBR?

Do insiders and institutionals believe in NVST or BRBR?

Summary

How does Envista compare to Zimmer Biomet?

Do institutionals and insiders have more ownership in ZBH or NVST?

Is ZBH or NVST more profitable?

Does the media prefer ZBH or NVST?

Which has stronger earnings and valuation, ZBH or NVST?

Which has more risk and volatility, ZBH or NVST?

Do analysts rate ZBH or NVST?

Summary

How does Envista compare to Smith & Nephew SNATS?

Do analysts recommend NVST or SNN?

Which has more volatility and risk, NVST or SNN?

Is NVST or SNN more profitable?

Does the media favor NVST or SNN?

Which has better earnings and valuation, NVST or SNN?

Do institutionals & insiders have more ownership in NVST or SNN?

Summary

How does Envista compare to Penumbra?

Do analysts recommend NVST or PEN?

Which has more volatility and risk, NVST or PEN?

Is NVST or PEN more profitable?

Does the media favor NVST or PEN?

Which has better earnings and valuation, NVST or PEN?

Do institutionals & insiders have more ownership in NVST or PEN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools